Health Care · Surgical & Medical Instruments & Apparatus · Nasdaq · CIK 1438133 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $18.59Day +4.67%Mkt cap $1.3B1Y +11.4%Off 52W high −37.3%Vol (1Y) 80.7%
Daily closing price, split-adjusted to the current basis; 3y shown of 3,191 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest19.1% of sh out |
| Days to cover8.7d |
| 13F net flow (QoQ)+2.86% |
| Top-10 13F concentration47.8% |
| Next report (est.)2026-08-07 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$1.03B |
| Earnings (TTM)-$94.5M |
| ROE−97.9% |
| Net margin−20.2% |
| ROIC−85.4% |
| Debt / equity2.00× |
| Sales growth 3Y8.2% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−15.4% |
| 1Y+11.4% |
| 3Y−46.8% |
| 5Y−82.4% |
| 10Y−72.0% |
| Since incept. (ann.)−16.8% |
Total return through 2026-07-29 · series begins 2013-11-14. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)80.7% |
| Ann. volatility (3Y)74.2% |
| Sharpe (1Y)0.51 |
| Sharpe (3Y)0.08 |
| Max drawdown (1Y)−54.6% |
| Max drawdown (3Y)−81.1% |
| Beta (3Y vs SPY)1.89 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| BlackRock, Inc. | 10.7M | $205M | 15.60% | −4.1% |
| Sessa Capital IM, L.P. | 4.7M | $91M | 6.90% | −5.4% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.0M | $77M | 5.83% | new |
| ArrowMark Colorado Holdings LLC | 3.1M | $59M | 4.53% | +7.4% |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.0M | $58M | 4.43% | new |
| GW&K Investment Management, LLC | 2.7M | $52M | 3.92% | +0.5% |
| STATE STREET CORP | 2.7M | $51M | 3.88% | +0.8% |
| Driehaus Capital Management LLC | 2.3M | $44M | 3.36% | +43.1% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. Institutional 13F holdings sum to 114.8% of shares outstanding. Readings above 100% reflect securities-lending double counting: shares on loan to short sellers are reported long by both the lending institution and the one that bought them. FINRA short interest of 9,723,853 shares (settlement 2026-04-30) accounts for the excess.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-07 | −$0.30 | — | $247.2M | +5.5% |
| 2025-12-31 | 2026-02-19 | −$0.01 | −200.0% | $290.4M | +2.7% |
| 2025-09-30 | 2025-11-06 | −$0.31 | — | $249.3M | +2.2% |
| 2025-06-30 | 2025-08-06 | −$0.78 | — | $240.7M | +8.5% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-07 is ESTIMATED from filing cadence (median gap 92d) — not company-confirmed.
US 70% · Non Us 30%
geographic · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
